Rare diseases
Investigational molecules
Locations
Study of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
FranceLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
FranceStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
FranceStudy on the Effectiveness and Safety of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
FranceStudy of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion
FranceStudy of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment
FranceStudy on the Effects of Lunsekimig (SAR443765) in Adults with High-Risk Asthma Not Eligible for Biologic Treatment
FranceStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
FranceStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
FranceStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
FranceStudy on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3
FranceStudy on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
